Farabegoli, F <br/><br/>
Suppressor of cytokine signalling 2 (SOCS-2) expression in breast carcinoma.  [electronic resource] 

 -  Journal of clinical pathology  Oct 2005 
 - 1046-50 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0021-9746 
<br/><br/><label>Standard No.: </label>10.1136/jcp.2004.024919  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Biomarkers, Tumor--metabolism<br/>Breast Neoplasms--metabolism<br/>Cell Cycle Proteins--metabolism<br/>Cell Proliferation<br/>Cyclin A--metabolism<br/>Cyclin-Dependent Kinase Inhibitor p27<br/>DNA-Binding Proteins--genetics<br/>ErbB Receptors--metabolism<br/>Female<br/>Humans<br/>In Situ Hybridization, Fluorescence<br/>Ki-67 Antigen--metabolism<br/>Middle Aged<br/>Neoplasm Proteins--genetics<br/>Repressor Proteins--genetics<br/>Retinoblastoma Protein--metabolism<br/>Suppressor of Cytokine Signaling Proteins<br/>Survival Rate<br/>Trans-Activators--genetics<br/>Tumor Suppressor Proteins--metabolism